InvestorsObserver
×
News Home

Does Black Diamond Therapeutics Inc (BDTX) Have What it Takes to be in Your Portfolio Wednesday?

Wednesday, February 28, 2024 01:58 PM | InvestorsObserver Analysts

Mentioned in this article

Does Black Diamond Therapeutics Inc (BDTX) Have What it Takes to be in Your Portfolio Wednesday?

Black Diamond Therapeutics Inc (BDTX) is near the top in its industry group according to InvestorsObserver. BDTX gets an overall rating of 83. That means it scores higher than 83 percent of stocks. Black Diamond Therapeutics Inc gets a 95 rank in the Biotechnology industry. Biotechnology is number 15 out of 148 industries.

Overall Score - 83
BDTX has an Overall Score of 83. Find out what this means to you and get the rest of the rankings on BDTX!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 83 would rank higher than 83 percent of all stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Black Diamond Therapeutics Inc Stock Today?

Black Diamond Therapeutics Inc (BDTX) stock is up 9.56% while the S&P 500 is down -0.08% as of 1:57 PM on Wednesday, Feb 28. BDTX is higher by $0.47 from the previous closing price of $4.89 on volume of 864,946 shares. Over the past year the S&P 500 has gained 27.81% while BDTX is higher by 202.82%. BDTX lost -$2.13 per share the over the last 12 months. Click Here to get the full Stock Report for Black Diamond Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App